{"created":"2024-10-31T01:37:11.084008+00:00","id":2020005,"links":{},"metadata":{"_buckets":{"deposit":"e2b89f35-aaae-4a10-8f56-d9392ec61d12"},"_deposit":{"created_by":7,"id":"2020005","owners":[7],"pid":{"revision_id":0,"type":"depid","value":"2020005"},"status":"published"},"_oai":{"id":"oai:ocu-omu.repo.nii.ac.jp:02020005","sets":["1623632832836:1721355153493"]},"author_link":[],"item_1617186331708":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Switching to tenofovir disoproxil fumarate vs continuing treatment in chronic hepatitis B patients who maintain long-term virological response to entecavir therapy: a randomized trial","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"作成者","attribute_type":"creator","attribute_value_mlt":[{"creatorAffiliations":[{"affiliationNames":[{"affiliationName":"Osaka City University","affiliationNameLang":"en"}]}],"creatorNames":[{"creatorName":"Iida-Ueno, Ayako","creatorNameLang":"en"},{"creatorName":"イイダ(ウエノ), アヤコ","creatorNameLang":"ja-Kana"},{"creatorName":"飯田(上野), 綾子","creatorNameLang":"ja"}]},{"creatorAffiliations":[{"affiliationNames":[{"affiliationName":"Osaka City University","affiliationNameLang":"en"}]}],"creatorNames":[{"creatorName":"Enomoto, Masaru","creatorNameLang":"en"},{"creatorName":"エノモト, マサル","creatorNameLang":"ja-Kana"},{"creatorName":"榎本, 大","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"1000020423874","nameIdentifierScheme":"KAKEN2","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000020423874"},{"nameIdentifier":"0000-0002-4028-4381","nameIdentifierScheme":"ORCID","nameIdentifierURI":"https://orcid.org/0000-0002-4028-4381"}]},{"creatorAffiliations":[{"affiliationNames":[{"affiliationName":"Osaka City University","affiliationNameLang":"en"}]}],"creatorNames":[{"creatorName":"Kozuka, Ritsuzo","creatorNameLang":"en"},{"creatorName":"コズカ, リツゾウ","creatorNameLang":"ja-Kana"},{"creatorName":"小塚, 立蔵","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"1000010726657","nameIdentifierScheme":"KAKEN2","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000010726657"}]},{"creatorAffiliations":[{"affiliationNames":[{"affiliationName":"Osaka City University","affiliationNameLang":"en"}]}],"creatorNames":[{"creatorName":"Tamori, Akihiro","creatorNameLang":"en"},{"creatorName":"タモリ, アキヒロ","creatorNameLang":"ja-Kana"},{"creatorName":"田守, 昭博","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"1000030291595","nameIdentifierScheme":"KAKEN2","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000030291595"},{"nameIdentifier":"0000-0001-9119-4864","nameIdentifierScheme":"ORCID","nameIdentifierURI":"https://orcid.org/0000-0001-9119-4864"}]},{"creatorAffiliations":[{"affiliationNames":[{"affiliationName":"Osaka City University","affiliationNameLang":"en"}]}],"creatorNames":[{"creatorName":"Kawada, Norifumi","creatorNameLang":"en"},{"creatorName":"カワダ, ノリフミ","creatorNameLang":"ja-Kana"},{"creatorName":"河田, 則文","creatorNameLang":"ja"}],"nameIdentifiers":[{"nameIdentifier":"1000030271191","nameIdentifierScheme":"KAKEN2","nameIdentifierURI":"https://nrid.nii.ac.jp/nrid/1000030271191"},{"nameIdentifier":"Hepatology","nameIdentifierScheme":"RESEARCHMAP","nameIdentifierURI":"https://researchmap.jp/Hepatology"}]}]},"item_1617186499011":{"attribute_name":"権利情報","attribute_value_mlt":[{"subitem_rights":"This is the peer reviewed version of the following article: Journal of Medical Virology, Volume91, Issue7, pp.1295-1300., which has been published in final form at https://doi.org/10.1002/jmv.25442 . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.","subitem_rights_language":"en"}]},"item_1617186609386":{"attribute_name":"主題","attribute_value_mlt":[{"subitem_subject":"エンテカビル","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"B型肝炎ウイルス","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"entecavir","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"hepatitis B virus","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"nucleos(t)ide analogs","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"randomized controlled trial (RCT)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"tenofovir disoproxil fumarate","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_1617186626617":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"No controlled trial in patients with chronic hepatitis B virus (HBV) infection on long-term entecavir (ETV) treatment, comparing switching to tenofovir disoproxil fumarate (TDF) with continuing the therapy, has been reported. Twenty-seven nucleos(t)ide-naïve patients with chronic HBV who underwent ETV therapy for ≥5 years and maintained virological response were included and randomized into two groups: one group continued ETV, and the other switched to TDF, in a 1:2 ratio. The primary endpoint was changed from baseline in serum hepatitis B surface antigen (HBsAg) level at week 48. The baseline characteristics were not different between nineteen patients in the TDF group and eight patients in the ETV group. Mean decreases in HBsAg level at week 48 were 0.023 an 0.042 log_10 IU/mL in the TDF and ETV groups, respectively (P = 0.94)....","subitem_description_language":"en","subitem_description_type":"Abstract"},{"subitem_description":"This research was supported in part by the Program for Basic and Clinical Research on Hepatitis of the Japan Agency for Medical Research and Development, Grant/Award Number: 16fk0210206h0002.","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_1617186643794":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Wiley","subitem_publisher_language":"en"}]},"item_1617186783814":{"attribute_name":"識別子","attribute_value_mlt":[{"subitem_identifier_type":"DOI","subitem_identifier_uri":"https://doi.org/10.1002/jmv.25442"}]},"item_1617186920753":{"attribute_name":"収録物識別子","attribute_value_mlt":[{"subitem_source_identifier":"1096-9071","subitem_source_identifier_type":"ISSN"}]},"item_1617187056579":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2019-07","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"7","bibliographicPageEnd":"1300","bibliographicPageStart":"1295","bibliographicVolumeNumber":"91","bibliographic_titles":[{"bibliographic_title":"Journal of Medical Virology","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_b1a7d7d4d402bcce","subitem_version_type":"AO"}]},"item_1617353299429":{"attribute_name":"関連情報","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1002/jmv.25442","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"AA11623598","subitem_relation_type_select":"NCID"}}]},"item_1722232185104":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-08-03"}],"displaytype":"detail","filename":"10969071-91-7-1295.pdf","filesize":[{"value":"636.2 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://ocu-omu.repo.nii.ac.jp/record/2020005/files/10969071-91-7-1295.pdf"},"version_id":"d312935e-9445-44cf-9abb-07bf51490f80"}]},"item_1722577087681":{"attribute_name":"記事種別等","attribute_value_mlt":[{"subitem_description":"RESEARCH ARTICLE","subitem_description_language":"en","subitem_description_type":"Other"}]},"item_1725590125188":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_title":"Switching to tenofovir disoproxil fumarate vs continuing treatment in chronic hepatitis B patients who maintain long-term virological response to entecavir therapy: a randomized trial","item_type_id":"40002","owner":"7","path":["1721355153493"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2020-08-03"},"publish_date":"2020-08-03","publish_status":"0","recid":"2020005","relation_version_is_last":true,"title":["Switching to tenofovir disoproxil fumarate vs continuing treatment in chronic hepatitis B patients who maintain long-term virological response to entecavir therapy: a randomized trial"],"weko_creator_id":"7","weko_shared_id":-1},"updated":"2024-10-31T01:37:19.186315+00:00"}